These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 20818481)
1. Evaluation of curcumin acetates and amino acid conjugates as proteasome inhibitors. Wan SB; Yang H; Zhou Z; Cui QC; Chen D; Kanwar J; Mohammad I; Dou QP; Chan TH Int J Mol Med; 2010 Oct; 26(4):447-55. PubMed ID: 20818481 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of curcumin derivatives modified with α-amino boronic acid as proteasome inhibitors. Zhang W; Bai H; Han L; Zhang H; Xu B; Cui J; Wang X; Ge Z; Li R Bioorg Med Chem Lett; 2018 Aug; 28(14):2459-2464. PubMed ID: 29886021 [TBL] [Abstract][Full Text] [Related]
3. Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo. Milacic V; Banerjee S; Landis-Piwowar KR; Sarkar FH; Majumdar AP; Dou QP Cancer Res; 2008 Sep; 68(18):7283-92. PubMed ID: 18794115 [TBL] [Abstract][Full Text] [Related]
4. A New Water-Soluble Nanomicelle Formed through Self-Assembly of Pectin-Curcumin Conjugates: Preparation, Characterization, and Anticancer Activity Evaluation. Bai F; Diao J; Wang Y; Sun S; Zhang H; Liu Y; Wang Y; Cao J J Agric Food Chem; 2017 Aug; 65(32):6840-6847. PubMed ID: 28721737 [TBL] [Abstract][Full Text] [Related]
5. Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2. Banerjee S; Ji C; Mayfield JE; Goel A; Xiao J; Dixon JE; Guo X Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8155-8160. PubMed ID: 29987021 [TBL] [Abstract][Full Text] [Related]
6. Deubiquitinase inhibition of 19S regulatory particles by 4-arylidene curcumin analog AC17 causes NF-κB inhibition and p53 reactivation in human lung cancer cells. Zhou B; Zuo Y; Li B; Wang H; Liu H; Wang X; Qiu X; Hu Y; Wen S; Du J; Bu X Mol Cancer Ther; 2013 Aug; 12(8):1381-92. PubMed ID: 23696216 [TBL] [Abstract][Full Text] [Related]
7. Arene-Ru(II) complexes of curcumin exert antitumor activity via proteasome inhibition and apoptosis induction. Bonfili L; Pettinari R; Cuccioloni M; Cecarini V; Mozzicafreddo M; Angeletti M; Lupidi G; Marchetti F; Pettinari C; Eleuteri AM ChemMedChem; 2012 Nov; 7(11):2010-20. PubMed ID: 22997162 [TBL] [Abstract][Full Text] [Related]
8. Curcumin: from ancient medicine to current clinical trials. Hatcher H; Planalp R; Cho J; Torti FM; Torti SV Cell Mol Life Sci; 2008 Jun; 65(11):1631-52. PubMed ID: 18324353 [TBL] [Abstract][Full Text] [Related]
9. Clinical development of novel proteasome inhibitors for cancer treatment. Yang H; Zonder JA; Dou QP Expert Opin Investig Drugs; 2009 Jul; 18(7):957-71. PubMed ID: 19505187 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological assessment of novel N-(hydroxy/methoxy)alkyl β-enaminone curcuminoids. Theppawong A; De Vreese R; Vannecke L; Grootaert C; Van Camp J; D'hooghe M Bioorg Med Chem Lett; 2016 Dec; 26(23):5650-5656. PubMed ID: 27843113 [TBL] [Abstract][Full Text] [Related]
11. Improving the anticancer activity of curcumin using nanocurcumin dispersion in water. Basniwal RK; Khosla R; Jain N Nutr Cancer; 2014; 66(6):1015-22. PubMed ID: 25068616 [TBL] [Abstract][Full Text] [Related]
12. An Ethanol Extract of Hawaiian Turmeric: Extensive In Vitro Anticancer Activity Against Human Colon Cancer Cells. Dimas K; Tsimplouli C; Houchen C; Pantazis P; Sakellaridis N; Tsangaris GT; Anastasiadou E; Ramanujam RP Altern Ther Health Med; 2015; 21 Suppl 2():46-54. PubMed ID: 26308760 [TBL] [Abstract][Full Text] [Related]
13. New difluoro Knoevenagel condensates of curcumin, their Schiff bases and copper complexes as proteasome inhibitors and apoptosis inducers in cancer cells. Padhye S; Yang H; Jamadar A; Cui QC; Chavan D; Dominiak K; McKinney J; Banerjee S; Dou QP; Sarkar FH Pharm Res; 2009 Aug; 26(8):1874-80. PubMed ID: 19421843 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel tripeptidyl epoxyketone derivatives constructed from β-amino acid as proteasome inhibitors. Zhang J; Cao J; Xu L; Zhou Y; Liu T; Li J; Hu Y Bioorg Med Chem; 2014 Jun; 22(11):2955-65. PubMed ID: 24767818 [TBL] [Abstract][Full Text] [Related]
15. Carboxymethylcellulose-tetrahydrocurcumin conjugates for colon-specific delivery of a novel anti-cancer agent, 4-amino tetrahydrocurcumin. Plyduang T; Lomlim L; Yuenyongsawad S; Wiwattanapatapee R Eur J Pharm Biopharm; 2014 Oct; 88(2):351-60. PubMed ID: 24859389 [TBL] [Abstract][Full Text] [Related]
16. A Novel Fluorescence-Labeled Curcumin Conjugate: Synthesis, Evaluation and Imaging on Human Cell Lines. Sheikh S; Sturzu A; Kalbacher H; Nagele T; Weidenmaier C; Horger M; Schwentner C; Ernemann U; Heckl S Curr Pharm Des; 2018; 24(16):1821-1826. PubMed ID: 29623828 [TBL] [Abstract][Full Text] [Related]
17. Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase. Yue X; Zuo Y; Ke H; Luo J; Lou L; Qin W; Wang Y; Liu Z; Chen D; Sun H; Zheng W; Zhu C; Wang R; Wen G; Du J; Zhou B; Bu X Biochem Pharmacol; 2017 Aug; 137():29-50. PubMed ID: 28476333 [TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits proteasome activity in triple-negative breast cancer cells through regulating p300/miR-142-3p/PSMB5 axis. Liu L; Fu Y; Zheng Y; Ma M; Wang C Phytomedicine; 2020 Nov; 78():153312. PubMed ID: 32866906 [TBL] [Abstract][Full Text] [Related]
19. Curcumin and cancer: barriers to obtaining a health claim. Devassy JG; Nwachukwu ID; Jones PJ Nutr Rev; 2015 Mar; 73(3):155-65. PubMed ID: 26024538 [TBL] [Abstract][Full Text] [Related]
20. Traditional Uses, Therapeutic Effects and Recent Advances of Curcumin: A Mini-Review. Slika L; Patra D Mini Rev Med Chem; 2020; 20(12):1072-1082. PubMed ID: 32286941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]